Acyclovir Injection, Powder, Lyophilized, For Solution
NDC Package 0143-9658-10
Package Information
Acyclovir injection is acyclovir for Injection is contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir. This formulation utilizes a injection, powder, lyophilized, for solution delivery system. Marketed by Hikma Pharmaceuticals Usa Inc., this product is identified by NDC 0143-9658 and is authorized under FDA application ANDA205771.
Identification & Billing
- RxCUI: 2263503 - acyclovir 1000 MG Injection
- RxCUI: 2263503 - acyclovir (as acyclovir sodium) 1000 MG Injection
- RxCUI: 2263503 - acycycloguanosine 1000 MG Injection
- RxCUI: 2263505 - acyclovir 500 MG Injection
- RxCUI: 2263505 - acyclovir (as acyclovir sodium) 500 MG Injection
Clinical Specifications
- DNA Polymerase Inhibitors - [MoA] (Mechanism of Action)
- Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Nucleoside Analog - [EXT]
Regulatory & Marketing
Hierarchy Structure
- 0143 - Hikma Pharmaceuticals Usa Inc.
- 0143-9658 - Acyclovir
- 0143-9658-10 - 10 VIAL, SINGLE-DOSE in 1 BOX / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0143-9658-01)
- 0143-9658 - Acyclovir
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0143-9658-10 identifies a specific commercial package of 10 vial, single-dose in 1 box / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose (0143-9658-01) of Acyclovir, a human prescription drug labeled by Hikma Pharmaceuticals Usa Inc.. This injection, powder, lyophilized, for solution is formulated for intravenous use and contains acyclovir sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hikma Pharmaceuticals Usa Inc. on February 29, 2016. The current certification is valid through December 31, 2026.
How is this Hikma Pharmaceuticals Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00143965810. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.